GREENSBORO, NORTH CAROLINA, USA, January 10, 2022 /EINPresswire.com/ – Piedmont Animal Health, the leader in veterinary pharmaceutical innovation, whose scientific team has been involved in the development and launch of more than 30 pet products worldwide, announced the appointment of Dr Eric Barnett as the new CEO. Roland Johnson, former CEO of Piedmont, will continue to serve as Chairman of the Board.
Eric Barnett is an experienced business executive in the life sciences and doctor of medicine. Barnett spent the early part of his career as a medical practitioner before training as a financial professional and moving into healthcare finance. He was previously a member of the clinical executive committee of GlaxoSmithKline, leading the capital management of the global R&D portfolio. Prior to this position, he held the position of CFO of a London hospital group.
Barnett’s unique expertise, developed over more than 30 years of experience in healthcare and pharmaceuticals, has been a critical contributor to Piedmont’s success over the past 13 years, having served as Executive Vice President business development and financial director before assuming his new role.
At Piedmont, Barnett has primarily focused on building and sustaining partnerships across the animal health industry. “The commercial side of Piedmont is based on successful partnerships. The world of pet health is small and it is essential to achieve win-win collaborations. My commitment will be to lead our business through ongoing and new partnerships, which will continue to be an important driver of our success, ”said Barnett.
“Having been involved at multiple levels in healthcare, both human and companion animal health, we look forward to Eric’s leadership as he steps into his new role in 2022 with many opportunities. exciting in progress. We greatly appreciate his extensive experience and expertise in the pharmaceutical industry, drug development and drug discovery, ”said Roland Johnson, former CEO and President of Piedmont. “I think people will agree that we’ve brought drugs to market that have made a real difference. I have great confidence in Eric’s ability to continue to strengthen Piedmont’s offerings and to maximize our potential.
2022 will be an important year for the company with several major product advancements in its development portfolio. To learn more about the targeted therapeutic categories and the company’s history of innovation, please visit PiedmontAnimalHealth.com
About Piedmont Animal Health
Piedmont Animal Health, Inc., a company based in North Carolina, USA, is led by a team of experienced and proven veterinary pharmaceutical innovators. A leader in innovation, Piedmont is dedicated to the development of new drugs that improve compliance and ease of use. Piedmont specializes in inventing, developing and obtaining FDA approval for drugs that address unmet animal health needs. For more information, visit PiedmontAnimalHealth.com
write us here